Alamar Biosciences, Inc. (ALMR)

NASDAQ: ALMR · Real-Time Price · USD

28.42

+1.94 (7.33%)

At close: Jul 10, 2026, 4:00 PM EDT

28.98

+0.56 (1.97%)

After-hours: Jul 10, 2026, 5:56 PM EDT

Alamar Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	74.21	25.14
Revenue Growth (YoY)	195.17%	-
Cost of Revenue	32.51	16.54
Gross Profit	41.71	8.61
Selling, General & Admin	35.57	18.94
Research & Development	37.47	39.23
Total Operating Expenses	73.04	58.18
Operating Income	-31.33	-49.57
Interest Income	2.16	4.68
Interest Expense	-0.4	-2.08
Other Non-Operating Income (Expense)	0.42	-0.09
Total Non-Operating Income (Expense)	2.18	2.51
Pretax Income	-29.15	-47.06
Provision for Income Taxes	0.67	0.01
Net Income	-29.82	-47.07
Net Income to Common	-29.82	-46.27
Shares Outstanding (Basic)	12	11
Shares Outstanding (Diluted)	12	12
Shares Change (YoY)	-2.89%	-
EPS (Basic)	-2.58	-4.40
EPS (Diluted)	-2.58	-4.60
Free Cash Flow	-58.98	-58.16
Free Cash Flow Per Share	-5.11	-4.89
Gross Margin	56.20%	34.23%
Operating Margin	-42.22%	-197.15%
Profit Margin	-40.18%	-187.23%
FCF Margin	-79.48%	-231.33%
EBITDA	-27.47	-46.37
EBITDA Margin	-37.02%	-184.45%
EBIT	-31.33	-49.57
EBIT Margin	-42.22%	-197.15%
Effective Tax Rate	-2.28%	-0.03%

SEC Filings: 10-K · 10-Q